BIOSYM A/S: Financial statements 2016
CVR: 21774189
Source: annual report 2016, Danish Business Authority
01/07/2015 – 30/06/2016
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 13,963,293 and a net result of DKK 5,604,542 compared with DKK 1,996,182 the year before. That is an increase of 82.8% compared with the year before. Equity in the 2016 report amounted to DKK 15,157,310. The solvency ratio was 63.9%.
- Gross Profit
- DKK 13,963,293
- Profit/Loss
- DKK 5,604,542
- Equity
- DKK 15,157,310
- Total Assets
- DKK 23,720,092
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 14 mio. | 5.6 mio. | 15.2 mio. | - |
| 2015 | - | 7.6 mio. | 2 mio. | 9.6 mio. | - |
| 2014 | - | 6.1 mio. | 1.5 mio. | 7.6 mio. | - |
| 2013 | - | -4.7 mio. | 555 t. | -6 mio. | - |
Official annual report
Find more companies like BIOSYM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorAbout BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 21 employees (2018). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.